Mo, C., Gasparetto, C., Costa, C., Cowan, A., Mark, T., Chai, Y., Kashyap, T., Katz, J., Amatangelo, M. and Richardson, P. (2026) “P43 | SELINEXOR, MEZIGDOMIDE, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO RELAPSED OR ARE INELIGIBLE FOR T-CELL–REDIRECTING THERAPY: STOMP PHASE 1 PRELIMINARY RESULTS”, Haematologica. Pavia, Italy, 111(s2). doi: 10.3324/haematol.2026.s2.14043.